The 2023 Life Sciences Investment Summit, hosted by Startup TNT and powered by Applied Pharmaceutical Innovation, is BACK!

Our goal is to raise hundreds of thousands of dollars for life sciences startups across Alberta, Saskatchewan and Manitoba and to create a syndicate of qualified angel investors who will help build up those startups.

If you’re raising money in 2023 for your life sciences startup, you don’t want to miss this opportunity.

We invite all life sciences companies that are considering raising money in 2023 to join us. Review the eligibility requirements to see if your company is a fit for this opportunity, applications are now being accepted.

Applications close on January 24th. The Top 20 Pitch Night will be on January 31st and the Summit Finale will be on March 23rd.

Over 60 companies have now raised over $8 million at Startup TNT Investment Summits – yours could be next!

Don’t miss this opportunity. Not only will you have the chance to connect with Startup TNT and API, but you’ll also have the chance to connect and build relationships with other summit partners including: Edmonton Unlimited, InnovateCalgary, HaloHealth, HealthCities, W21C, dealcloser, UCeed, Accelerate Fund, Thin Air Labs.

How the Process Works

3 provinces. 1 Guaranteed winner. Side Deals Expected

30 companies

30+ Companies

apply and are evaluated by the investors with a process designed and facilitated by Startup TNT

20 30 investors

20-30 Investors

pre-commit $5,000 each for the winner and conduct team based due diligence over an 8 week period

20 companies

20 Companies

undergo due diligence and participate in the Top 20 Pitch Night (virtual) on February 9th

5 finalists

5 Finalists

negotiate deal terms and get to pitch at the Life Sciences Summit Finale in Calgary on March 23rd

20 companies

Fundraising Goal

Expected investment into the winner is $200k-$500k

  • $150k+ from the individual angels and $50k from the VC fund, syndicated together as one cheque
  • $25K-$250K side deals into additional companies!

PRESENTED IN PARTNERSHIP WITH

Life Sciences Summit Partnership With